What is Abbott Laboratories's expected EPS for Q3 2026?

Analysts expect Abbott Laboratories (ABT) to report consensus EPS of approximately $1.42 for Q3 2026. Estimates range from $1.41 to $1.44.

What revenue do analysts expect for Abbott Laboratories in Q3 2026?

The consensus revenue forecast for Abbott Laboratories (ABT) in Q3 2026 is approximately $13B. Forecasts range from $12.9B to $13.2B.

How many analysts cover Abbott Laboratories?

14 analysts contribute to the Abbott Laboratories (ABT) Q3 2026 consensus estimate.

Has Abbott Laboratories beaten earnings estimates recently?

Abbott Laboratories beat analyst EPS estimates in 2 of the last 2 quarters. Abbott Laboratories beat revenue estimates in 2 of 2. In the most recent quarter (Q2 2026), Abbott Laboratories EPS beat by 2.6% and revenue beat by 0.6%.

When does Abbott Laboratories report Q3 2026 earnings?

Abbott Laboratories (ABT) is expected to report Q3 2026 earnings on October 14, 2026 before market open.

ABT Q3 2026 earnings estimate

Consensus EPS · Q3 2026

$1.42

Consensus revenue · Q3 2026

$13B

Analysts

Expected report

Oct 14, 2026

Before open

Upcoming earnings

Locks in 82 days 13 hours · BMO: Locks 8:00 PM ET previous day

Revenue$13B$12.9B – $13.2B

EPS$1.42$1.41 – $1.44

What to watch

Analyst ratings: Mixed

Make your prediction

Analyst consensus

Based on estimates from 14 analysts.

Metric	Low	Consensus	High
Revenue	$12.9B	$13B	$13.2B
EPS	$1.41	$1.42	$1.44
EBITDA	$3.5B	$3.5B	$3.5B
EBIT	$2.5B	$2.5B	$2.5B
Net income	$2.5B	$2.5B	$2.5B

Revenue$13B
EPS$1.42
EBITDA$3.5B
EBIT$2.5B
Net income$2.5B

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

Period	Rev. actual	Rev. est.	Rev. surprise	EPS actual	EPS est.	EPS surprise
Q2 2026	$12.6B	$12.5B	+0.6%	$1.31	$1.28	+2.6%
Q1 2026	$11.2B	$11B	+1.5%	$1.15	$1.14	+0.5%

Q2 2026+0.6%+2.6%
Q1 2026+1.5%+0.5%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for Abbott Laboratories (ABT) Q3 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 5 analysts.

Low: $92.00
Consensus: $122.29
Median: $120.50
High: $145.00
Current: $100.57
Upside: +21.6%

Upside calculated vs most recent trading price of $100.57.

Consensus across all covering analysts. See the ranking ›

$122.29+21.60%

Analyst ratings

Consensus: Buy — based on 41 analyst ratings.

Buy 31Hold 10

24-month trend

Recent analyst actions

Date	Firm	Action	From	To
Jul 17, 2026	Wells Fargo	maintain	Overweight	Overweight
Jul 17, 2026	TD Cowen	maintain	Buy	Buy
Jul 17, 2026	RBC Capital	maintain	Outperform	Outperform
Jul 17, 2026	Piper Sandler	maintain	Overweight	Overweight
Jul 17, 2026	JP Morgan	maintain	Overweight	Overweight
Jul 17, 2026	Evercore ISI Group	maintain	Outperform	Outperform
Jul 17, 2026	Citigroup	maintain	Buy	Buy
Jul 17, 2026	BTIG	maintain	Buy	Buy
Jul 6, 2026	Evercore ISI Group	maintain	Outperform	Outperform
Jun 22, 2026	Piper Sandler	maintain	Overweight	Overweight

Jul 17, 2026Wells FargoOverweight
Jul 17, 2026TD CowenBuy
Jul 17, 2026RBC CapitalOutperform
Jul 17, 2026Piper SandlerOverweight
Jul 17, 2026JP MorganOverweight
Jul 17, 2026Evercore ISI GroupOutperform
Jul 17, 2026CitigroupBuy
Jul 17, 2026BTIGBuy
Jul 6, 2026Evercore ISI GroupOutperform
Jun 22, 2026Piper SandlerOverweight

Frequently asked questions

Abbott Laboratories (ABT) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

ABT Overview

Counters

Income Statement

Cash Flow

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

Forecast & Valuation